Dolby Laboratories (NYSE:DLB) SVP Sells $450,666.26 in Stock

Dolby Laboratories (NYSE:DLB) SVP John Couling sold 7,667 shares of the firm’s stock in a transaction dated Thursday, October 1st. The stock was sold at an average price of $58.78, for a total value of $450,666.26. Following the transaction, the senior vice president directly owned 166,803 shares in the company, valued at approximately $9,804,680.34. The trade was a 4.39% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

Dolby Laboratories Stock Performance

Dolby Laboratories stock opened at $58.32 on Thursday. Dolby Laboratories has a fifty-two week low of $48.26 and a fifty-two week high of $71.34. The company has a market capitalization of $5.46 billion, a P/E ratio of 24.82 and a beta of 0.78. The stock has a 50-day simple moving average of $60.75 and a 200-day simple moving average of $57.57.

Dolby Laboratories (NYSE:DLB) last released its quarterly earnings results on Thursday, July 30th. The electronics maker reported $0.69 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.67 by $0.02. The firm had revenue of $305.00 million for the quarter, compared to the consensus estimate of $311.96 million. Dolby Laboratories had a return on equity of 11.08% and a net margin of 16.70%.The firm’s quarterly revenue was down 3.3% compared to the same quarter last year. During the same quarter last year, the business posted $0.78 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. As a group, analysts forecast that Dolby Laboratories will post 3.23 earnings per share for the current year.

Dolby Laboratories Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, August 19th. Stockholders of record on Tuesday, August 11th were given a dividend of $0.36 per share. The ex-dividend date was Tuesday, August 11th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.5%. Dolby Laboratories’s dividend payout ratio (DPR) is 61.28%.

Dolby Laboratories declared that its Board of Directors has approved a share repurchase plan on Thursday, July 30th that allows the company to repurchase $350.00 million in outstanding shares. This repurchase authorization allows the electronics maker to purchase up to 7% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s board of directors believes its stock is undervalued.

Analyst Upgrades and Downgrades

DLB has been the topic of several research reports. Wall Street Zen downgraded shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Barrington Research reiterated an “outperform” rating and set a $90.00 target price on shares of Dolby Laboratories in a research note on Monday, June 15th. Rosenblatt Securities reissued a “buy” rating and set a $85.00 price target on shares of Dolby Laboratories in a report on Friday, August 28th. Finally, Weiss Ratings upgraded Dolby Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, September 9th. Two research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $87.50.

Hedge Funds Weigh In On Dolby Laboratories

A number of large investors have recently bought and sold shares of DLB. Caitong International Asset Management Co. Ltd boosted its holdings in shares of Dolby Laboratories by 73,900.0% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 1,480 shares of the electronics maker’s stock valued at $95,000 after acquiring an additional 1,478 shares in the last quarter. Nykredit A S purchased a new position in Dolby Laboratories during the second quarter worth about $101,000. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in Dolby Laboratories during the second quarter worth about $216,000. Signet Financial Management LLC acquired a new stake in Dolby Laboratories in the first quarter valued at about $231,000. Finally, Corient Private Wealth LP acquired a new stake in Dolby Laboratories in the second quarter valued at about $234,000. Hedge funds and other institutional investors own 58.56% of the company’s stock.

About Dolby Laboratories

Dolby Laboratories, Inc develops audio and imaging technologies for entertainment and communications. The company’s products and intellectual property are used in cinemas, televisions, mobile devices, personal computers, streaming platforms, gaming systems and automobiles to improve sound quality, picture quality and overall viewing experiences.

Dolby’s technology portfolio includes Dolby Atmos immersive audio, Dolby Vision high-dynamic-range imaging, and Dolby Digital and Dolby AC-4 audio formats.